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Available online 13 December 2011Abstract Embryonic stem cells (ESCs) hold great potential for replacing neurons following injury or disease. The therapeutic
and diagnostic potential of ESCs may be hindered by heterogeneity in ESC-derived populations. Drug selection has been used to
purify ESC-derived cardiomyocytes and endothelial cells but has not been applied to specific neural lineages. In this study we
investigated positive selection of progenitor motor neurons (pMNs) through transgenic expression of the puromycin resistance
enzyme, puromycin N-acetyl-transferase (PAC), under the Olig2 promoter. The protein-coding region in one allele of Olig2 was
replaced with PAC to generate the P-Olig2 cell line. This cell line provided specific puromycin resistance in cells that express
Olig2, while Olig2− cells were killed by puromycin. Positive selection significantly enriched populations of Olig2+ pMNs. Com-
mitted motoneurons (MNs) expressing Hb9, a common progeny of pMNs, were also enriched by the end of the selection period.
Selected cells remained viable and differentiated into mature cholinergic MNs and oligodendrocyte precursor cells. Drug resis-
tance may provide a scalable and inexpensive method for enriching desired neural cell types for use in research applications.
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doi:10.1016/j.scr.2011.12.003cell populations are hindered by limited numbers, variable
proliferation in response to disease, and in some cases, dif-
ferentiation into glia rather than neurons (Barnabe-Heider
et al., 2010; Meletis et al., 2008; Yang et al., 2006; Baker
et al., 2004). Embryonic stem cells (ESCs) can be differenti-
ated into specific neuronal subtypes and may be useful for
cell replacement strategies in the central nervous system
(Sonntag et al., 2007). Transplantation of ESC-derived dopa-
minergic neurons and cholinergic motoneurons (MNs) has been
shown to promote partial recovery from Parkinson's-like symp-
toms and spinal cord injury, in rodent models (Roy et al.,
2006; Erceg et al., 2010). Heterogeneous populations arising
from differentiation of ESCs, however, currently limit the
efficacy of such treatments (Gogel et al., 2011). Strategies for
controlled differentiation of ESCs and the subsequent
369Transgenic enrichment of progenitor motor neuronsenrichment ESC-derived cells types are therefore critical to the
development of ESC-based therapies and diagnostic screening
tools.
Directed differentiation of ESCs into spinal MNs can be
achieved following exposure to retinoic acid (RA) and sonic
hedgehog (Shh) (Wichterle and Peljto, 2008; Wichterle et al.,
2002). During this process, ESCs first differentiate into progeni-
tor motor neurons (pMNs) expressing the basic helix–loop–helix
transcription factor Olig2 (Mizuguchi et al., 2001; Novitch et al.,
2001). These cells can commit to the MN fate by downregu-
lating Olig2 and expressing the homeodomain (HD) tran-
scription factors Islet 1 (Isl1) and Hb9, also known as Mnx1
(Mizuguchi et al., 2001; Novitch et al., 2001; Arber et al.,
1999; Pfaff et al., 1996). Despite optimization, differentia-
tion protocols for pMNs result in a heterogeneous population
of cells including other ventral spinal progenitor cells
(Wichterle et al., 2002). Hb9+-committed MNs compose only
15–50% of the total culture after differentiation of ESCs
(Wichterle and Peljto, 2008; Deshpande et al., 2006). Low-
purity cultures give rise to multiple types of spinal interneu-
rons, therefore subsequent enrichment may be necessary
(Deshpande et al., 2006).
Greater pMN purity can be obtained by fluorescence-
activated cell sorting (FACS) of a transgenic ESC line that ex-
presses GFP under the Olig2 gene regulatory elements (GRE)
(Xian et al., 2005; Xian and Gottlieb, 2004; Xian and
McNichols, 2003). This method, however, requires expensive
equipment andmust be performedat a centralized facility, risk-
ing contamination. Gradient centrifugation can enrich spinal
MNs from the mouse embryonic lumbar spinal cord and human
ESCs, but has not been optimized for mouse ESC-derived MNs
(Wada et al., 2009; Wiese et al., 2010). Transgenic selection
may provide a low-cost alternative and can be performed di-
rectly in the culture dish. Puromycin resistance through expres-
sion of the enzyme puromycin N-acetyl-transferase (PAC) has
been shown to allow enrichment of ESC-derived cardiomyocytes
and endothelial cells in transgenic lines (Marchetti et al., 2002;
Kim and von Recum, 2009; Kolossov et al., 2006; Anderson et
al., 2007), but has not been used to enrich specific neural
populations.
In this study, we investigated whether transgenic selection
could help to enrich low-purity populations that commonly re-
sult from pMN differentiation protocols. We generated a new
heterozygous “knock in” mouse ESC line (P-Olig2) where the
protein-coding region in one allele of Olig2 was replaced with
PAC, allowing for positive selection of Olig2+ pMNs during the
differentiation. Olig2 expression was analyzed during directed
differentiation of ESCs into pMNs using the Shh signaling agonist,
purmorphamine (Sinha and Chen, 2006; Wu et al., 2004).
Puromycin-treated cells were assessed for expression of pMN-
specific markers and differentiation into pMN progeny, includ-
ing MNs and oligodendrocytes. This study demonstrates the
first use of puromycin resistance for positive selection of a spe-
cific population of neural progenitor cells.Results
Olig2 expression during differentiation of ESCs
To determine the effect of Shh signaling levels on directed
differentiation of ESCs into pMNs, we analyzed mRNA levelsin response to increasing concentrations of purmorphamine,
a Shh agonist, using quantitative real time (RT)-PCR. ESCs
were exposed to 2 μM retinoic acid (RA) and 250 nM,
500 nM, or 1 μM purmorphamine. Relative mRNA levels
were analyzed at the end of the 2−/4+ differentiation proto-
col and were compared to control cells that did not receive
RA or purmorphamine (n=3 for all conditions). Increasing
the purmorphamine concentration from 250 nM to 1 μM led
to downregulation of Dbx2 and Irx3, two transcription fac-
tors found in p1 and p2 progenitor (more dorsal) domains, re-
spectively (Figs. 1A–B). The mRNA levels for Pax6, which is
expressed in the p1, p2, and pMN domains, did not change
with concentration. Nkx2.2 mRNA levels were too low for
detection even at the highest concentration of purmorpha-
mine (data not shown). Olig2 expression significantly in-
creased with exposure to 1 μM purmorphamine compared
to 250 nM and 500 nM purmorphamine (Fig. 1C). HD tran-
scription factors Isl1 and Hb9 expressed during commitment
of pMNs to the MN fate were upregulated with 1 μM purmor-
phamine, similar to Olig2. Finally, 1 μM purmorphamine led
to an increase in mRNA for choline acetyltransferase
(ChAT), an enzyme found specifically in mature MNs.
Heterogeneity in differentiated cultures
To characterize the heterogeneity of the cell population
resulting from differentiation of ESCs, we utilized a trans-
genic ESC line expressing GFP under the Olig2 GRE, G-Olig2
(Xian and Gottlieb, 2004). GFP fluorescence can persist for
several days after transcription, allowing for identification
of pMNs and their recent progeny during differentiation. By
visual inspection of GFP fluorescence, pMNs could be easily
separated from other spinal progenitor cells that differenti-
ate into spinal interneurons rather than MNs.
G-Olig2 ESCs were differentiated using 1 μM purmorpha-
mine and 2 μM RA and analyzed by flow cytometry. At the
end of the 2−/4+ differentiation protocol, 61.6±4.5% of
cells expressed GFP (n=3). This percentage was approxi-
mately 3-fold higher than expression of Olig2 found with tra-
ditional antibody staining, suggesting that GFP fluorescence
persists in recent pMN progeny as expected. GFP− cells were
consistently found migrating away from EBs and displayed a
broad flat morphology typical of astrocytes or astrocyte pre-
cursor cells (ASPs) (Figs. 2D–F; white arrows). These cells
may originate from the p2 progenitor domain that gives
rise to ASPs in vivo (Muroyama et al., 2005). Additional
GFP− cells were present within EBs with a similar morpholo-
gy to Olig2+ pMNs and may represent progenitor cells from
adjacent progenitor domains (white asterisk).
Generating the P-Olig2 cell line
The P-Olig2 cell line was generated using a targeting vector
with a resistance cassette in the open reading frame of the
Olig2 gene surrounded by two regions homologous to the
Olig2 locus. RW4 ESCs were electroporated with the P-Olig2
targeting vector and homologous recombination occurred as
illustrated in (Fig. 3A). To confirm targeted insertion, novel
junctions were detected using short arm junction PCR. Suc-
cessful integration resulted in a 2.1 kb fragment spanning
from inside the targeting construct into neighboring genomic
Figure 1 Transcription factor expression during directed
differentiation of ESCs. (A): schematic of transcription factors
expressed in spinal progenitor domains. Ventral-to-dorsal gradi-
ent of sonic hedgehog (Shh) and relative position of spinal pro-
genitor domains in the ventral neural tube are shown on the
left. The pattern of transcription factor expression in each
domain is shown on the right. (B): expression of p1 and p2 pro-
genitor genes in ESCs differentiated with the Shh signaling ago-
nist, purmorphamine, and retinoic acid (RA) using a 2−/4+
differentiation protocol. Data are expressed as the fold differ-
ence in mRNA levels compared to ESCs differentiated without
purmorphamine and RA. (C): expression of pMN and MN specific
genes in differentiated ESCs. * indicates pb0.05 for that gene
compared to ESCs exposed to 250 nM purmorphamine. # indi-
cates pb0.05 for that gene compared to ESCs exposed to
500 nM purmorphamine. Abbreviations: FP, floor plate; ChAT,
choline acetyl transferase; Isl1, Islet 1.
370 D.A. McCreedy et al.DNA (Fig. 3B). The addition of the resistance cassette increased
the distance between HindIII sites within the Olig2 locus from
4.8 kb to 6.7 kb as observed by Southern analysis (Fig. 3C).
Only the 4.8 kb band was observed in control RW4 cells while
both bands were observed in the P-Olig2 cell line. The appear-
ance of both bands confirms that only one of the two Olig2 loci
was targeted. Following insertion, the floxed PGK-neo cassette
was excised with Cre recombinase as confirmed using PCR by a
new 350 bp band (Fig. 3D). The final cell line contained a
promoter-less PAC cassette driven by the Olig2 GRE (Fig. 4A).To determine the specificity of PAC expression, P-Olig2
and RW4 ESCs were differentiated into pMNs, and the ex-
pression of Olig2 and PAC mRNA was assessed using PCR.
Olig2 and PAC mRNA was not observed or present at very
low levels in ESCs and ESCs aggregated into EBs (Fig. 4B).
Following the 2−/4+ differentiation protocol, Olig2 mRNA
levels were elevated in both P-Olig2 and RW4 cell lines.
PAC mRNA, however, was specific to the P-Olig2 cell line.
Specificity of PAC expression in the P-Olig2 cell line was con-
firmed by sensitivity to puromycin. Few P-Olig2 ESCs sur-
vived following exposure to puromycin for 48 h (Fig. 4C)
since the Olig2 gene is off or expressed at very low levels.
In contrast, many viable cells were observed in cultures of
P-Olig2 ESCs differentiated into pMNs, which express Olig2
(Fig. 4D). Widespread cell death was still observed in the lat-
ter group, suggesting the presence of Olig2− cells that do not
express PAC and are sensitive to puromycin.Enrichment of pMNs using the P-Olig2 cell line
To determine whether transgenic selection enriched the cell
population for pMNs and committed MNs, P-Olig2 cells were
differentiated using 2 μM RA and 1.5 μM purmorphamine
with a 2−/4+ differentiation protocol. Puromycin was added
during the last 2 days to select for Olig2+ pMNs (Fig. 5A). Con-
trol groups consisted of RW4 and P-Olig2 cells not receiving pu-
romycin. Similar to G-Olig2 cell cultures, broad Olig2− cells
were observed migrating out of the EB in the control P-Olig2
group (Fig. 5B). In cultures with puromycin, these cells were
not present. Cellular debris localizing to the same region sug-
gests that puromycin-induced cell death occurred in Olig2−
cells. Themajority of surviving cells had a progenitor-likemor-
phology and expressed Olig2 or Hb9.
To assess cell differentiation in control and selected cul-
tures, cells were stained at the end of the differentiation pro-
tocol with phenotype-specific markers and analyzed using
flow cytometry. Puromycin selection did not affect the distri-
bution of Nestin+ cells, suggesting that the majority of cells
were neural cells. The percentage of Olig2+ cells increased sig-
nificantly from 21.9±5.9% to 48.7±7.3% when selected with
puromycin (Fig. 5C). Hb9+ populations were enriched from
20.6±7.9% to 58.5±1.5%. Similar enrichment was observed
for Isl1. No significant differences were found for any marker
between the RW4 and control P-Olig2 (non-selected) groups.Undifferentiated stem cells
To determine the effect of puromycin exposure on Oct4+
undifferentiated stem cells, cultures were fixed and analyzed
following immunocytochemistry (ICC). The overall percentage
of cells expressing the pluripotent stem cell marker Oct4 fol-
lowing the 2−/4+ differentiation was low (b1%) in control
and selected groups (data not shown). The fraction of 2−/4+
EBs containing at least one Oct4+ nuclei was compared be-
tween unselected and selected P-Olig2 pMNs on day 6. Oct4+
cells were commonly found in small groups and were limited
to unselected P-Olig2 cultures (Fig. 6A). Approximately 10%
of EBs contained undifferentiated stem cells in the absence
of puromycin (Fig. 6B). Oct4+ nuclei were not observed in
any of the cultures selected with puromycin.
Figure 2 Heterogeneity following directed differentiated of G-Olig2 ESCs. (A): phase contrast image of differentiated G-Olig2 ESCs
following exposure to purmorphamine and RA. (B): expression of green fluorescent protein (GFP) in (A) showing cells that have
expressed Olig2 during differentiation. (C): corresponding Hoechst staining showing cell nuclei. Scale bars=100 μM. (D–F) Close in-
spection of GFP- cells (white arrows) with astrocyte-like morphology that did not differentiate into pMNs expressing Olig2. Additional
GFP− cells with progenitor-like morphology were found within EBs (white asterisk). Scale bars=50 μM.
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To determinewhether targeted replacement of the Olig2 gene
impacted the ability of ESC-derived pMNs to terminally differ-
entiate, we cultured puromycin selected P-Olig2 cells for
2 weeks on laminin-coated wells. Following differentiation,
cells were assessed for expression of ChAT and neurofilament
(NF) using ICC to identify mature MNs. Cultures were also
stained for oligodendrocyte marker 4 (O4) and RIP to identify
oligodendrocytes, another common progeny of pMNs. Groups
of ChAT+/NF+ neurons were abundant throughout the culture
(Fig. 7). Oligodendrocytes expressing O4 and RIP were alsopresent (Fig. 7). These results demonstrate that cells surviving
the puromycin selection differentiate into neurons and oligo-
dendrocytes, the expected progeny of Olig2+ pMNs.Discussion
Current protocols for differentiation of mouse ESCs are often
hindered by low efficiencies. Directed differentiation may
lead to heterogeneous ESC-derived populations that must
be further purified to obtain the desired lineages prior to
cell culture studies or transplantation. In this study, we
Figure 3 Knock-in to replace Olig2 ORF with PAC gene. (A): Olig2 gene is a schematic of the Olig2 gene. The smaller black boxes
represent the two exons of the Olig2 gene with the ORF (large black box) located in the second exon. The 5′ probe and H (HindIII)
sites used for Southern blots are indicated. P-Olig2 vector shows the targeting vector with the PAC and floxed neo cassette in
place of the ORF. P-Olig2-neo is the predicted knock-in product with the predicted 6.7 Kb HindIII fragment and the 2.1 Kb junction
PCR product shown. P-Olig2 shows the engineered gene after Cre-excision of the floxed neo cassette. (B): junction PCR of control
RW4 cells and targeted cells. Amplified DNA is absent in the RW4 cells but present in the targeted (P-Olig2) cells. (C): Southern
blots–RW4 parental cells have native 4.8 Kb HindIII band; targeted (POlig2) cells have additional 6.7 Kb band. (D) Cre-excision of
neo cassette- PCR reactions across neo cassette show amplified DNA in Cre+ cells but not in untreated (Cre−) cells.
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transgenic expression of the puromycin resistance enzyme
PAC can provide a simple method for enrichment of pMNs.
Purmorphamine exhibited a dose-dependent effect on pMN
gene expression during directed differentiation of G-Olig2
ESCs. Greater concentrations of purmorphamine led to a signif-
icant increase in Olig2 expression. Conversely, expression of
Dbx2 and Irx3 (more dorsal transcription factors) were reduced
with increasing concentrations of purmorphamine. Nkx2.2,
which is expressed in the more ventral p3 progenitor domain,
was not detected in any of the conditions tested. Based on
the gene expression data, directed differentiation appears to
favor pMNs at the highest concentration of purmorphamine
tested. However, this condition still resulted in a mixed cell
population with nearly 40% of cells not expressing Olig2. This
undesired population may include cells from neighboring pro-
genitor domains that have been previously observed following
directed differentiation of ESCs into pMNs (Wichterle et al.,
2002). Differentiation of ESCs into cells from multiple spinal
progenitor domains is potentially due to overlapping depen-
dency on Shh signaling in the ventral neural tube or our inability
to precisely control localized concentration of purmorphamine
over the duration of the experiment. Furthermore, variations
in the responsiveness of each cell to Shh signalingmay attribute
to heterogeneity.Positive selection of cardiomyocytes and endothelial cells
through puromycin resistance has been previously shown
using randomly inserted resistance cassettes containing a
cell-type specific promoter (Marchetti et al., 2002; Kim and
von Recum, 2009; Kolossov et al., 2006). By knocking in PAC ex-
pression, we preserve regulatory mechanisms for the native
Olig2 gene. Expression of PAC in the final P-Olig2 cell line reca-
pitulated expression of Olig2 in the native allele. Specificity of
the PAC cassette driven by the native Olig2 GRE was shown by
puromycin sensitivity. Cell death was induced in puromycin
treated P-Olig2 ESCs within 48 h which is similar to the time-
course previously described for puromycin-induced cell death
(Watanabe et al., 1995). Only when P-Olig2 ESCswere differen-
tiated into pMNs using the 2−/4+ differentiation protocol did
cells remain viable following puromycin treatment. Cell
death was still observed in differentiated ESC cultures suggest-
ing that only cells having expressed Olig2 show resistance. Con-
sistent with this hypothesis, puromycin treatment removed all
broad flat cells previously identified as Olig2−. In addition, pu-
romycin killed all Olig2−/Oct4+ undifferentiated stem cells.
The majority of remaining viable cells were positive for the
transcription factors Olig2 or Hb9. These results demonstrate
selective resistance in pMNs and their progeny.
Differentiation of non-selected P-Olig2 ESCs was similar
to RW4 ESCs for all markers tested in this study. Substituting
Figure 4 PAC and Olig2 expression in the P-Olig2 cell line (A): schematic of the PAC cassette driven by the native Olig2 GRE.
(B): Olig2 and PAC mRNA expression in P-Olig2 and RW4 cell lines. Expression was analyzed in ESCs, ESCs aggregated into embryoid
bodies (EBs), and ESCs differentiated into pMNs using a 2−/4+ treatment protocol. (C): Live/Dead assay showing live cells (green)
and dead cells (red) following exposure of undifferentiated P-Olig2 and RW4 ESCs to puromycin for 48 h. (D): Live/dead assay for
differentiated P-Olig2 and RW4 EBs selected with puromycin for 48 h. Fluorescent cell debris was observed in the RW4 group whereas
the P-Olig2 group contained whole viable cells.
373Transgenic enrichment of progenitor motor neuronsPAC for one copy of the Olig2 gene did not appear to alter
differentiation of P-Olig2 ESCs into pMNs or commitment of
pMNs to the MN fate. Following puromycin treatment, Olig2+
pMNs were significantly enriched. High purity pMN cultures
were not obtained in this study; perhaps this is due to the per-
sistence of the PAC enzyme in committed Hb9+ MNs. Commit-
ted MNs were enriched nearly 3-fold and constituted the
majority of cells at the end of the selection. This population
may become further enriched as additional Olig2+ pMNs commit
to the MN fate. The distribution of Nestin+ cells was not affect-
ed by puromycin treatment, suggesting that themajority Olig2−
cells killed by puromycin were neural lineage cells. These cells
could be other spinal progenitor cells that express Nestin.
The long-term effects of PAC knock-in and puromycin expo-
sure were assessed through differentiation of puromycin-
treated pMNs on laminin. Following a twoweek differentiation
period, ChAT+/NF+ MNs and O4+/RIP+ immature oligodendro-
cytes were observed. These results demonstrate long-term vi-
ability of enriched pMNs and committed MNs, suggesting no
persistent effects of puromycin exposure. Oligodendrocyte
development from pMNs is dependent on continuous Olig2 ex-
pression (Xian and Gottlieb, 2004), and does not appear to be
disturbed by the PAC knock-in. Both MNs and oligodendrocytes
have been transplanted for treatment of SCI (Keirstead et al.,
2005; Sharp et al., 2010) and are potential target populations
for cell replacement strategies in other neurological disordersincluding amyotrophic lateral sclerosis and multiple sclerosis.
Additional enrichment strategies can be employed to purify
individual populations of MNs or oligodendrocytes.Conclusions
Many studies in developmental biology, drug screening, and
regenerative medicine can benefit from high purity ESC-
derived cell populations. This study demonstrates the use of
puromycin resistance to select for a well-defined set of neural
progenitor cells following directed differentiation of ESCs.
Themethods utilized in this study can be applied to other neu-
ral cell types to generate high-purity populations that can im-
prove the use of ESC-derived populations in research.Materials and methods
Embryonic stem cell culture
The RW4 ESC line was used to generate and characterize the
P-Olig2 cell line. Olig2 expression was characterized using
the G-Olig2 ESC line that expresses GFP under the control
of the Olig2 GRE (Xian et al., 2005; Xian and Gottlieb,
2004; Xian and McNichols, 2003). ESCs were grown in
Figure 5 Positive selection of P-Olig2 ESCs differentiated using a 2−/4+ differentiation protocol. (A): schematic showing 2−/4+ differ-
entiation protocol of ESCs. Puromycin was added from day 4 and remained till day 6. (B): Immunocytochemistry analysis of P-Olig2 ESCs
following differentiation and puromycin selection. Olig2+ and Hb9+ cells compose a small fraction of the entire population in the absence
of puromycin. Following puromycin treatment, the majority of cells expressed either Olig2 or Hb9. (C): Nestin expression in control and
selected P-Olig2 cultures. The majority of cells express Nestin. (D): Flow cytometry histograms and gating. Solid black histograms repre-
sent secondary antibody controls. (E): Flow cytometry analysis of RW4, non-selected P-Olig2, and puromycin selected P-Olig2 ESCs follow-
ing differentiation. * indicates pb0.05 for that marker compared to unselected P-Olig2 group. Scale bars=100 μM.
374 D.A. McCreedy et al.complete media consisting of Dulbecco's modified Eagle's
Medium (DMEM; Invitrogen, Carlsbad, CA, http://www.
invitrogen.com) supplemented with 10% newborn calf
serum (Invitrogen), 10% fetal bovine serum (Invitrogen),
10 μM thymidine (Sigma, St. Louis, MO, http://www.
sigmaaldrich.com), and 30 μM of each of the following nu-
cleosides: adenosine, cytosine, guanosine, and uridine
(Sigma). Cells were passaged at a 1:5 ratio every 2 days
and seeded on a new T25 flask coated with a 0.1% gelatin so-
lution (Sigma). After seeding, 1000 U/ml leukemia inhibitory
factor (LIF; Millipore, Billerica, MA, http://www.millipore.
com) and 100 μM β-mercaptoethanol (BME; Invitrogen)
were added to the media to maintain the undifferentiated
state of the ESCs without the need for a feeder cell layer.Generation of P-Olig2 ESCs
The P-Olig2 cell line was generated from the RW4 line. Ap-
proximately 1×107 RW4 ESCs were resuspended in electro-
poration buffer with 10–15 μg of ScaI-linearized P-Olig2
targeting vector. The targeting vector was constructed
from a Gateway-compatible plasmid (pStartK) incorporatingthe Olig2 locus with the Olig2 open reading frame replaced
by a dual resistance cassette consisting of from 5′ to 3′:
Asc1 site, Kozak sequence, puromycin cassette with bgh
polyA signal (PKO-Select Puro, Agilent Genomics, Santa
Clara, CA, http://www.genomic.agilent.com), floxed phos-
phoglycerate kinase I promoter driving the neomycin phos-
photransferase gene (PGK-neo) with bgh polyA signal, and
AscI site (Thomas and Capecchi, 1987; Wu et al., 2008;
Kozak, 1986). Cells were electroporated using an Amaxa
nucleofector II (Lonza, Basel, Switzerland, http://www.
lonzabio.com) at 0.23 kV and 960 μF in a 0.4 cm cuvette
(Bio-Rad, Hercules, CA, http://www.bio-rad.com). Follow-
ing electroporation, cells were seeded on gelatin coated
10 cm dishes for 24 h then dosed with G418 (200 μg/ml, Invi-
trogen) and 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-
iodouracil (FIAU; 100 nM, Movarek Biochemicals, Brea, CA,
http://www.moravek.com) for positive and negative selec-
tion respectively. After 8 days, resistant clones were picked
and seeded on a mouse embryonic fibroblast STO monolayer
in individual wells of a 96 well plate to promote growth of
low density ESC clones. Clones were screened for targeting
events by PCR using standard methods. Targeted clones
were detected and further characterized.
Figure 6 Oct4 expression in P-Olig2 cells following the 2−/4+ differentiation protocol. (A): a small group of Oct4+ nuclei in an
unselected, control P-Olig2 EB. (B): fraction of EBs containing Oct4+ nuclei in control and selected P-Olig2 cultures. * indicates
pb0.05 compared to unselected P-Olig2 group.
Figure 7 Immunocytochemistry performed on selected pMNs differentiated for 2 weeks on laminin. (A): ChAT and respective
(B): NF expression in differentiated cultures showing mature cholinergic motoneurons. Differentiation also led to expression of
(C): O4 and (D): RIP showing immature and mature oligodendrocytes respectively. Scale bars=100 μM. Abbreviations: ChAT, choline
acetyl transferase; NF, neurofilament; O4, oligodendrocyte marker 4.
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Genomic DNA was isolated from RW4 and P-Olig2 ESCs using
the ArchivePure DNA Cell/Tissue and Tissue Kit (5 Prime, Gai-
thersburg, MD, http://www.5prime.com). DNA-binding pro-
teins were digested with Proteinase K. Genomic DNA was
digested with 200 U HindIII or 50 U SpeI overnight at 37 °C. Re-
striction enzymes were re-applied for an additional hour then
DNA was ethanol precipitated. DNA restriction fragments
were separated by electrophoresis. DNA was transferred to a
Hybond-XL (GE Healthcare Biosciences, Piscataway, NJ,
http://www.gehealthcare.com) membrane and crosslinked
using a UV Stratalinker 2400 (Stratagene). DNA probes were
prepared with the Rediprime Kit (GE Healthcare Bioscience)
and [32P] dCTP (Perkin-Elmer, Waltham, Massachusetts,
http://www.perkinelmer.com). Probes were purified using
illustra ProbeQuantG-50 columns (GE Healthcare Biosciences).
Blots were hybridized in Rapid hybe (GE Healthcare Biosci-
ences) for 2 h at 65 °C, then washed and visualized by
autoradiography.Cre-excision
To remove the floxed PGK-neo resistance cassette, 2×106
ESCs were transfected with 5 μg of Cre recombinase expres-
sing plasmid (p1411, gift of Tim Ley, Washington University).
Removal of the PGK-neo cassette was confirmed using junc-
tion PCR. Cre-excised clones were further subcloned and re-
validated by PCR and neomycin sensitivity.
Live Dead assay
Live/Dead reagent (Invitrogen) consisting of calcien-AM and
ethidium homodimer was used to visualize live and dead
cells, respectively. Wells were washed with Dulbecco's PBS
and incubated with 1× Live/Dead reagent for 30 min at
room temp. Fluorescent images were captured using Meta-
Vue image analysis software (Molecular Devices, Sunnyvale,
CA, http://www.moleculardevices.com) and a Nikon
TE200S fluorescence microscope.
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For pMN induction, ESCs were exposed to RA (Sigma) and
purmorphamine (EMD, Gibbstown, NJ, http://www.
emdchemicals.com) in a 2−/4+ differentiation protocol.
One million ESCs were aggregated into embryoid bodies
(EBs) in 100-mm Petri dishes coated with a 0.1% agar solution
in DFK5 media consisting of DMEM:F12 base media (Invitro-
gen) supplemented with 5% knockout serum replacement
(Invitrogen), 50 μg/ml apo-transferrin (Sigma), 50 μM non-
essential amino acids (Invitrogen), 5 μg/ml insulin (Sigma),
30 nM sodium selenite (Sigma), 100 μM β-mercaptoethanol,
5 μM thymidine, and 15 μM of the following nucleosides:
adenosine, cytosine, guanosine, and uridine. EBs were
allowed to form for 2 days in the absence of inducing fac-
tors, then split 1:5 and transferred to 6-well plates coated
with 0.1% gelatin solution. Once plated, the EBs were
grown for an additional 4 days in DFK5 supplemented with
2 μM RA and 250 nM–1.5 μM purmorphamine. Media was
changed every 2 days. In selected cultures, 2 ng/ml puromy-
cin (Sigma) was added during the final 2 days of
differentiation.Quantitative real time polymerase chain reaction
(qRT-PCR)
The relative expression level of progenitor cell transcription
factors and markers for MN differentiation were assessed
using quantitative real-time polymerase chain reaction (qRT-
PCR). EBs were lysed with Trizol reagent (Invitrogen) and
RNA was isolated using an RNeasy kit (Qiagen, Germantown,
MD, http://www.qiagen.com). Isolated RNA was used to syn-
thesize cDNA for qRT-PCR analysis using the TaqMan 2-Step
RNA-to-CT Mini Kit (Applied Biosystems, Carlsbad, CA,
http://www.appliedbiosystems.com). TaqMan Gene Expres-
sion Assays (Table 1, Applied Biosystems), TaqMan Gene Ex-
pression Master Mix (Applied Biosystems) and cDNA were
combined and qRT-PCR was performed using an Applied Bio-
systems 7000 thermocycler with the following PCR protocol:
50 °C for 2 min, 95 °C for 10 min, and 40 cycles of 95 °C for
15 s, 55 °C for 30 s and 72 °C for 30 s. 6-carboxyfluorescein
(FAM) fluorescent detection occurred during each 72 °C
cycle. Relative mRNA expression was reported as the number
of cycles necessary for fluorescent intensity to increase expo-
nentially, referred to as the threshold cycle (Ct). All target
genes were normalized to ß-actin to account for differencesTable 1 List of applied biosystems gene expression assay
IDs.
Gene Primer ID
Dbx2 Mm01306497_m1
Irx3 Mm00500463_m1
Pax6 Mm00443072_m1
Olig2 Mm01210556_m1
Nkx2.2 Mm00839794_m1
Islet1 Mm00517585_m1
Hb9 Mm00658300_g1
Choline acetyltransferase Mm01221882_m1
β-Actin Mm02619580_g1in total mRNA content. Expression in EBs induced with 2 μM
RA and 250 nM, 500 nM, or 1 μM purmorphamine was deter-
mined using the comparative ΔCt method, with EBs receiving
neither RA nor purmorphamine serving as the control group
(Schmittgen and Livak, 2008). Results are reported as a fold
difference in relative RNA expression over control EBs (n=3
for each condition).
Flow cytometry
Differentiated ESC cultures were stained immediately fol-
lowing the 2−/4+ treatment protocol for flow cytometry
analysis. Cultures were dissociated with trypsin–EDTA
(0.25%; Invitrogen) for 15 min and triturated to form single
cell suspensions. Excess volume of complete media was
added to quench the trypsin, and cells were centrifuged for
5 min at 230×g. The media was aspirated and cells were
fixed with 1% paraformaldehyde (Sigma). After fixation, the
cells were permeabilized with 0.5% saponin (Sigma) solution
for 20 min, and then blocked in 0.1% saponin solution contain-
ing 5% normal goat serum (NGS; Sigma). Cell suspensions were
then incubated for 30 min in 0.1% saponin solution containing
2% NGS and one of the following primary antibodies: Nestin
(Iowa Hybridoma Bank; 1:10), Isl1 (Iowa Hybridoma Bank;
1:50), Hb9 (MRN2; Iowa Hybridoma Bank; 1:25), and Olig2
(Millipore; 1:500). Cells were washed with PBS and appropri-
ate Alexa Fluor secondary antibodies (1:200; Invitrogen) dilut-
ed in 0.5% saponin with 2% NGS were applied for 30 min.
Finally cells were washed with PBS and incubated with
Hoechst (1:1000; Invitrogen) for 5 min.
Stained cell suspensions were analyzed using a Canto II
flow cytometer (Becton Dickinson, Franklin Lakes, NJ). For
each group, 10,000 events were recorded. Subsequent anal-
ysis was performed using FloJo software (FloJo, Ashland, OR,
http://www.flojo.com). Prior to population gating, debris
was removed based on forward scatter versus side scatter
and Hoechst fluorescence versus forward scatter plots.
Flow cytometry control groups, consisting of cells stained
with the secondary antibody only, were used to determine
quadrant population gating parameters. Flow cytometry re-
sults are presented as the percentage of cells staining posi-
tive for each marker out of the total live cell population.
Immunocytochemistry
Cell distribution and identity was assessed in differentiated
cultures using immunocytochemistry (ICC). Cell cultures
were fixedwith 1% paraformaldehyde for 30 min then permea-
bilized in 0.01% Triton X (Sigma) for 15 min. The cells were
blocked with 5% NGS for 1 h at 4 °C and incubated overnight
at 4 °C in 2% NGS solution with one or more of the following
primary antibodies: Oct4 (1:500, Santa Cruz Biotechnology,
Santa Cruz, CA, http://www.scbt.com), Olig2 (1:500), Isl1
(1:20), Hb9 (1:20), Nestin (1:10), neurofilament (NF, DSHB,
1:25), choline acetyl transferase (ChAT, Millipore, 1:400), oli-
godendrocytes (RIP, Millipore, 1:5000), and oligodendrocyte
marker 4 (O4, Milllipore, 1:500). Primary antibody staining
was followed by 3 washes in an excess volume of PBS for
15 min each. Each culture was then stained with the appropri-
ate Alexa Fluor secondary antibodies (Invitrogen) for 1 h at
4 °C followed by an additional 3 washes in PBS. Cell nuclei
377Transgenic enrichment of progenitor motor neuronswere stained with the nuclei binding dye Hoechst (1:1000).
Fluorescent images were captured using a MICROfire camera
attached to an Olympus IX70 inverted microscope. Images
were analyzed using Image Pro Express (Media Cybernetics,
Silver Spring, MD, http://www.mediacy.com).
Undifferentiated ESCs
To quantify the occurrence of Oct4+ undifferentiated stem
cells following the 2−/4+ differentiation protocol, P-Olig2
cultures were fixed and stained with the Oct4 antibody.
EBs containing at least one Oct4+ nuclei were counted and
divided by the total number of EBs to determine the fraction
of EBs containing undifferentiated stem cells. At least 50 EBs
per sample were assessed for Oct4 expression.
Differentiation of pMNs
For pMN differentiation, 24-well plates were pre-coated
with 0.01% poly(ornithine) solution (Sigma) then coated
with 0.01 mg/ml laminin solution (Invitrogen) overnight. In-
duced 2−/4+ EBs were dissociated and plated at a density
of 100,000 cells/ml in DFK5 media. After 5 days, media
were replaced with Neurobasal media (Invitrogen) supple-
mented with 0.1% bovine serum albumin (Sigma) and 2%
B27 (Invitrogen). Cells were allowed to differentiate an ad-
ditional 9 days.
Statistical analysis
For qRT-PCR and flow cytometry analyses, 3 replicates of
each condition were performed. Statistical analysis was per-
formed in Statistica software (version 5.5; StatSoft; OK,
www.statsoft.com). Multiple comparison statistics were ac-
complished using Scheffe's post hoc test for analysis of vari-
ance (ANOVA) with a 95% confidence level. Values are
reported as the mean plus or minus standard deviation.
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